These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 14583871)

  • 1. Mortality risk for patients with cytomegalovirus retinitis and acquired immune deficiency syndrome.
    Kempen JH; Jabs DA; Wilson LA; Dunn JP; West SK; Tonascia J
    Clin Infect Dis; 2003 Nov; 37(10):1365-73. PubMed ID: 14583871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence of cytomegalovirus (CMV) retinitis in second eyes of patients with the acquired immune deficiency syndrome and unilateral CMV retinitis.
    Kempen JH; Jabs DA; Wilson LA; Dunn JP; West SK
    Am J Ophthalmol; 2005 Jun; 139(6):1028-34. PubMed ID: 15953432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytomegalovirus retinitis in the era of highly active antiretroviral therapy.
    Kedhar SR; Jabs DA
    Herpes; 2007 Dec; 14(3):66-71. PubMed ID: 18371289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence of and risk factors for visual acuity loss among patients with AIDS and cytomegalovirus retinitis in the era of highly active antiretroviral therapy.
    Thorne JE; Jabs DA; Kempen JH; Holbrook JT; Nichols C; Meinert CL;
    Ophthalmology; 2006 Aug; 113(8):1432-40. PubMed ID: 16766032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics of untreated AIDS-related cytomegalovirus retinitis. II. Findings in the era of highly active antiretroviral therapy (1997 to 2000).
    Holland GN; Vaudaux JD; Shiramizu KM; Yu F; Goldenberg DT; Gupta A; Carlson M; Read RW; Novack RD; Kuppermann BD;
    Am J Ophthalmol; 2008 Jan; 145(1):12-22. PubMed ID: 18154751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discontinuation of secondary prophylaxis in patients with cytomegalovirus retinitis who have responded to highly active antiretroviral therapy.
    Berenguer J; González J; Pulido F; Padilla B; Casado JL; Rubio R; Arribas JR;
    Clin Infect Dis; 2002 Feb; 34(3):394-7. PubMed ID: 11753827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between cytomegalovirus-specific reactivity of T cell subsets and development of cytomegalovirus retinitis in patients with acquired immunodeficiency syndrome.
    Hsieh SM; Pan SC; Hung CC; Tsai HC; Chen MY; Chang SC
    J Infect Dis; 2001 Dec; 184(11):1386-91. PubMed ID: 11709780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of cytomegalovirus retinitis on the quality of life of patients with AIDS in the era of highly active antiretroviral therapy.
    Kempen JH; Martin BK; Wu AW; Barron B; Thorne JE; Jabs DA;
    Ophthalmology; 2003 May; 110(5):987-95. PubMed ID: 12750102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cytomegalovirus infection in HIV].
    Ferone U; Cerimele C; Isceri L; Trinchieri V; Proietti F; Galati V; Monacelli M
    Riv Eur Sci Med Farmacol; 1994; 16(3-4):55-60. PubMed ID: 7480960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cystoid macular edema and cytomegalovirus retinitis in AIDS patients treated with antiretroviral triple therapy].
    Badelon I; Gohier P; Chaine G
    J Fr Ophtalmol; 1999 Dec; 22(10):1034-41. PubMed ID: 10617840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prospective multicentre study of discontinuing prophylaxis for opportunistic infections after effective antiretroviral therapy.
    Green H; Hay P; Dunn DT; McCormack S;
    HIV Med; 2004 Jul; 5(4):278-83. PubMed ID: 15236617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prognosis of CMV retinitis among patients with AIDS in Serbia.
    Dujić M; Jevtović Dj; Salemović D; Ranin J; Brmbolić B; Djurković-Djaković O
    Biomed Pharmacother; 2008 Sep; 62(7):443-7. PubMed ID: 18243635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The changing pattern of cytomegalovirus retinitis in human immunodeficiency virus disease.
    Au Eong KG; Beatty S; Charles SJ
    Singapore Med J; 2000 Jun; 41(6):298-300. PubMed ID: 11109349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A brighter future for the AIDS patient.
    Lowell E; Van Tassell B
    Insight; 2002; 27(4):95-6. PubMed ID: 12520982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytomegalovirus retinitis and immune recovery uveitis in AIDS patients treated with highly active antiretroviral therapy in Taiwanese.
    Lin YC; Yang CH; Lin CP; Yang CM; Chen MS; Chen MY; Sheng WH; Hung CC; Chang SC
    Ocul Immunol Inflamm; 2008; 16(3):83-7. PubMed ID: 18569793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pulmonary complications in patients with AIDS].
    Oka S
    Kekkaku; 2002 Jan; 77(1):37-40. PubMed ID: 11855078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immune recovery in AIDS patients: changes in the clinical presentation and therapy of cytomegalovirus retinitis].
    Zamir E
    Harefuah; 2000 Dec; 139(11-12):454-7. PubMed ID: 11341194
    [No Abstract]   [Full Text] [Related]  

  • 18. CMV after HAART.
    Posit Aware; 1998; 9(5):18, 23. PubMed ID: 11365888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Causes of visual acuity loss among patients with AIDS and cytomegalovirus retinitis in the era of highly active antiretroviral therapy.
    Thorne JE; Jabs DA; Kempen JH; Holbrook JT; Nichols C; Meinert CL;
    Ophthalmology; 2006 Aug; 113(8):1441-5. PubMed ID: 16781775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors associated with the occurrence of AIDS-related non-Hodgkin lymphoma in the era of highly active antiretroviral therapy: Aquitaine Cohort, France.
    Bonnet F; Balestre E; Thiébaut R; Morlat P; Pellegrin JL; Neau D; Dabis F;
    Clin Infect Dis; 2006 Feb; 42(3):411-7. PubMed ID: 16392091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.